Sable · Question
What is the difference between LL-37 and Tirzepatide?
LL-37 is the 37-residue active fragment of the human cathelicidin hCAP18, studied in antimicrobial-peptide and innate-immunity research (peptide, MW about 4493 g/mol).
Research use only. Not for human consumption. No health claims.
Last verified 2026-10-10
What is the difference between LL-37 and Tirzepatide?
LL-37 is the 37-residue active fragment of the human cathelicidin hCAP18, studied in antimicrobial-peptide and innate-immunity research (peptide, MW about 4493 g/mol).
Which is heavier, LL-37 or Tirzepatide?
LL-37 has a molecular weight of about 4493 g/mol and Tirzepatide about 4813 g/mol (PubChem), so Tirzepatide is heavier by 320 g/mol, a ratio of 1.07. This means 1 mg of LL-37 contains 222.6 nmol versus 207.8 nmol for Tirzepatide.
How many mg of Tirzepatide are equimolar to 1 mg of LL-37?
1 mg of LL-37 (MW 4493) is 222.6 nmol. The same number of moles of Tirzepatide (MW 4813) weighs 1.071 mg. Equimolar comparisons matter when testing two compounds side by side in the same assay.
Compare the molecular formulas of LL-37 and Tirzepatide
PubChem lists LL-37 as C205H340N60O53 (4493 g/mol) and Tirzepatide as C225H348N48O68 (4813 g/mol). LL-37 is a peptide; Tirzepatide is a peptide (lipidated). These formulas refer to the parent compounds without salt counter-ions.
A 10 mg vial of LL-37 equals how many mg of Tirzepatide in moles?
10 mg of LL-37 (MW 4493) is 2.226 µmol. The same amount of Tirzepatide (MW 4813) would weigh 10.712 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 5 mg vial of LL-37 equals how many mg of Tirzepatide in moles?
5 mg of LL-37 (MW 4493) is 1.113 µmol. The same amount of Tirzepatide (MW 4813) would weigh 5.356 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 20 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
20 mg of Tirzepatide (MW 4813) is 4.155 µmol. The same amount of LL-37 (MW 4493) would weigh 18.67 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 10 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
10 mg of Tirzepatide (MW 4813) is 2.078 µmol. The same amount of LL-37 (MW 4493) would weigh 9.335 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 5 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
5 mg of Tirzepatide (MW 4813) is 1.039 µmol. The same amount of LL-37 (MW 4493) would weigh 4.668 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 30 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
30 mg of Tirzepatide (MW 4813) is 6.233 µmol. The same amount of LL-37 (MW 4493) would weigh 28.005 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 40 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
40 mg of Tirzepatide (MW 4813) is 8.311 µmol. The same amount of LL-37 (MW 4493) would weigh 37.341 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 15 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
15 mg of Tirzepatide (MW 4813) is 3.117 µmol. The same amount of LL-37 (MW 4493) would weigh 14.003 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 60 mg vial of Tirzepatide equals how many mg of LL-37 in moles?
60 mg of Tirzepatide (MW 4813) is 12.466 µmol. The same amount of LL-37 (MW 4493) would weigh 56.011 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A CoA for every lot; each vial carries a printed lot number that matches it. Ask with the lot number and we send it.
Cite this
Research use only. Not for consumption. No health claims.
Plain
Sable Peptides. (2026). What is the difference between LL-37 and Tirzepatide?. UK Research Peptide Reference. Retrieved 11 October 2026, from https://www.sablepeptides.co.uk/questions/compare/ll-37-vs-tirzepatide/#sqa-039910
APA
Sable Peptides. (2026, October 11). *What is the difference between LL-37 and Tirzepatide?*. UK Research Peptide Reference. https://www.sablepeptides.co.uk/questions/compare/ll-37-vs-tirzepatide/#sqa-039910
BibTeX
@misc{sable_#sqa-039910_2026,
author = {{Sable Peptides}},
title = {{What is the difference between LL-37 and Tirzepatide?}},
year = {2026},
howpublished = {\url{https://www.sablepeptides.co.uk/questions/compare/ll-37-vs-tirzepatide/#sqa-039910}},
note = {Accessed 11 October 2026. CC BY 4.0}
}Badge
<a href="https://www.sablepeptides.co.uk/ref"><img src="https://www.sablepeptides.co.uk/badge/ref.svg" alt="Data: UK Research Peptide Reference — Sable Peptides" width="220" height="40"></a>
Date modified: 2026-10-10